These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32641587)

  • 1. RAGE impairs murine diabetic atherosclerosis regression and implicates IRF7 in macrophage inflammation and cholesterol metabolism.
    Senatus L; López-Díez R; Egaña-Gorroño L; Liu J; Hu J; Daffu G; Li Q; Rahman K; Vengrenyuk Y; Barrett TJ; Dewan MZ; Guo L; Fuller D; Finn AV; Virmani R; Li H; Friedman RA; Fisher EA; Ramasamy R; Schmidt AM
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes.
    Daffu G; Shen X; Senatus L; Thiagarajan D; Abedini A; Hurtado Del Pozo C; Rosario R; Song F; Friedman RA; Ramasamy R; Schmidt AM
    Diabetes; 2015 Dec; 64(12):4046-60. PubMed ID: 26253613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 22016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis and Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.
    Schmidt AM
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):613-621. PubMed ID: 28183700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin.
    Machado-Lima A; López-Díez R; Iborra RT; Pinto RS; Daffu G; Shen X; Nakandakare ER; Machado UF; Corrêa-Giannella MLC; Schmidt AM; Passarelli M
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
    Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integral role of receptor for advanced glycation end products (RAGE) in nondiabetic atherosclerosis.
    Uekita H; Ishibashi T; Shiomi M; Koyama H; Ohtsuka S; Yamamoto H; Yamagishi S; Inoue H; Itabe H; Sugimoto K; Kamioka M; Ohkawara H; Wada I; Yasuchika T
    Fukushima J Med Sci; 2019; 65(3):109-121. PubMed ID: 31915324
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin Blocks Advanced Glycation End Products Induced Reduction in Macrophage Cholesterol Efflux Mediated With ATP-Binding Cassette Transporters G 1.
    Xu L; Wang YR; Li PC; Feng B
    Circ J; 2019 Aug; 83(9):1954-1964. PubMed ID: 31378770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell-mediated chronic low-grade inflammation is regulated by the RAGE-TLR4-PKCβ
    Zhao L; Li Y; Xu T; Lv Q; Bi X; Liu X; Fu G; Zou Y; Ge J; Chen Z; Zhang W
    Mol Med; 2022 Jan; 28(1):4. PubMed ID: 35062863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
    Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAGE/DIAPH1 and atherosclerosis through an evolving lens: Viewing the cell from the "Inside - Out".
    Ramasamy R; Shekhtman A; Schmidt AM
    Atherosclerosis; 2024 Jul; 394():. PubMed ID: 39131441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages.
    Nguyen MA; Hoang HD; Rasheed A; Duchez AC; Wyatt H; Cottee ML; Graber TE; Susser L; Robichaud S; Berber İ; Geoffrion M; Ouimet M; Kazan H; Maegdefessel L; Mulvihill EE; Alain T; Rayner KJ
    Circ Res; 2022 Jun; 131(1):42-58. PubMed ID: 35611698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis.
    Liu M; Yu Y; Jiang H; Zhang L; Zhang PP; Yu P; Jia JG; Chen RZ; Zou YZ; Ge JB
    Acta Pharmacol Sin; 2013 Jun; 34(6):830-6. PubMed ID: 23564080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage Lxrα reduces atherosclerosis in Ldlr
    Yin Y; Zeng S; Li Y; Wu Z; Huang D; Gao P
    Biochem Biophys Res Commun; 2020 Aug; 529(3):540-547. PubMed ID: 32736671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.
    Flynn MC; Kraakman MJ; Tikellis C; Lee MKS; Hanssen NMJ; Kammoun HL; Pickering RJ; Dragoljevic D; Al-Sharea A; Barrett TJ; Hortle F; Byrne FL; Olzomer E; McCarthy DA; Schalkwijk CG; Forbes JM; Hoehn K; Makowski L; Lancaster GI; El-Osta A; Fisher EA; Goldberg IJ; Cooper ME; Nagareddy PR; Thomas MC; Murphy AJ
    Circ Res; 2020 Sep; 127(7):877-892. PubMed ID: 32564710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice.
    Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM
    Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus.
    Kawakami R; Katsuki S; Travers R; Romero DC; Becker-Greene D; Passos LSA; Higashi H; Blaser MC; Sukhova GK; Buttigieg J; Kopriva D; Schmidt AM; Anderson DG; Singh SA; Cardoso L; Weinbaum S; Libby P; Aikawa M; Croce K; Aikawa E
    Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1838-1853. PubMed ID: 32460581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications.
    Ramasamy R; Shekhtman A; Schmidt AM
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone Attenuates Atherosclerosis in Diabetic Mice by Inhibition of Receptor for Advanced Glycation End-Product (RAGE) Signaling.
    Gao H; Li H; Li W; Shen X; Di B
    Med Sci Monit; 2017 Dec; 23():6121-6131. PubMed ID: 29278639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.